Home › Therapeutic areas › Cardiovascular › Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease (3 companies)
Companies with an active program in Atherosclerotic Cardiovascular Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| BIOA | BioAge Labs | CardiovascularOphthalmology | 1 | Phase 2 | $245M | 2 |
| GLUE | Monte Rosa Therapeutics | CardiovascularDermatology+3 Rare | 1 | Phase 2 | $903M | 7 |
| NAMS | NewAmsterdam Pharma | CardiovascularMetabolic+1 | 1 | NDA Submitted | $2.27B | 6 |
No companies match.